STOCK TITAN

[8-K] Crown Holdings Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

CRA International (CRAI) Form 4 filing: Director Christine Rose Detrick received 696 shares of common stock on 17 Jul 2025 at $0, lifting her direct ownership to 6,139 shares. The award is restricted stock that vests 25% annually starting on the first anniversary of the grant, encouraging long-term alignment with shareholders. No derivatives were exercised and no shares were sold or transferred. The addition raises the director’s stake by about 13% but represents well under 0.01% of the company’s outstanding shares, so dilution and market impact are negligible. While insider accumulation is directionally positive, the economic value is modest and does not materially alter CRAI’s capital structure or investment thesis.

Deposito del Modulo 4 di CRA International (CRAI): La direttrice Christine Rose Detrick ha ricevuto 696 azioni ordinarie il 17 luglio 2025 al prezzo di $0, portando la sua partecipazione diretta a 6.139 azioni. Il premio consiste in azioni vincolate che maturano il 25% ogni anno a partire dal primo anniversario della concessione, favorendo un allineamento a lungo termine con gli azionisti. Non sono stati esercitati derivati né sono state vendute o trasferite azioni. L'incremento aumenta la quota della direttrice di circa il 13%, ma rappresenta meno dello 0,01% delle azioni in circolazione della società, quindi la diluizione e l'impatto sul mercato sono trascurabili. Sebbene l'accumulazione da parte degli insider sia un segnale positivo, il valore economico è modesto e non modifica sostanzialmente la struttura del capitale o la tesi d'investimento di CRAI.

Presentación del Formulario 4 de CRA International (CRAI): La directora Christine Rose Detrick recibió 696 acciones ordinarias el 17 de julio de 2025 a $0, aumentando su propiedad directa a 6,139 acciones. La concesión consiste en acciones restringidas que se liberan en un 25% anual a partir del primer aniversario de la concesión, fomentando una alineación a largo plazo con los accionistas. No se ejercieron derivados ni se vendieron o transfirieron acciones. Esta adición incrementa la participación de la directora en aproximadamente un 13%, pero representa menos del 0,01% de las acciones en circulación de la empresa, por lo que la dilución y el impacto en el mercado son insignificantes. Aunque la acumulación interna es un signo positivo, el valor económico es modesto y no altera materialmente la estructura de capital ni la tesis de inversión de CRAI.

CRA International (CRAI) Form 4 제출: 이사 Christine Rose Detrick는 2025년 7월 17일에 696주의 보통주를 $0에 받았으며, 직접 소유 주식 수는 6,139주로 증가했습니다. 이 수여는 제한 주식으로, 부여 1주년부터 매년 25%씩 베스팅되어 주주와의 장기적 일치를 촉진합니다. 파생상품 행사는 없었고 주식도 매도 또는 이전되지 않았습니다. 이번 추가로 이사의 지분은 약 13% 증가했지만, 회사 발행 주식의 0.01% 미만에 해당하여 희석 및 시장 영향은 미미합니다. 내부자 매입은 긍정적인 신호이나 경제적 가치는 크지 않으며 CRAI의 자본 구조나 투자 논리를 실질적으로 변경하지 않습니다.

Dépôt du formulaire 4 de CRA International (CRAI) : La directrice Christine Rose Detrick a reçu 696 actions ordinaires le 17 juillet 2025 à 0 $, portant sa participation directe à 6 139 actions. Cette attribution correspond à des actions restreintes qui se libèrent à hauteur de 25 % chaque année à partir du premier anniversaire de la concession, favorisant ainsi un alignement à long terme avec les actionnaires. Aucun dérivé n’a été exercé et aucune action n’a été vendue ou transférée. Cette augmentation accroît la participation de la directrice d’environ 13 %, mais représente bien moins de 0,01 % des actions en circulation de la société, de sorte que la dilution et l’impact sur le marché sont négligeables. Bien que l’accumulation par les initiés soit un signal positif, la valeur économique reste modeste et ne modifie pas substantiellement la structure du capital ni la thèse d’investissement de CRAI.

CRA International (CRAI) Form 4 Einreichung: Direktorin Christine Rose Detrick erhielt am 17. Juli 2025 696 Stammaktien zu $0, wodurch ihr Direktbesitz auf 6.139 Aktien anstieg. Die Zuteilung besteht aus beschränkten Aktien, die ab dem ersten Jahrestag der Gewährung jährlich zu 25 % freigegeben werden, um eine langfristige Ausrichtung mit den Aktionären zu fördern. Es wurden keine Derivate ausgeübt und keine Aktien verkauft oder übertragen. Die zusätzliche Beteiligung erhöht den Anteil der Direktorin um etwa 13 %, stellt jedoch weniger als 0,01 % der ausstehenden Aktien des Unternehmens dar, sodass Verwässerung und Markteinfluss vernachlässigbar sind. Obwohl die Insider-Akkumulation positiv zu bewerten ist, ist der wirtschaftliche Wert gering und ändert die Kapitalstruktur oder die Investmentthesis von CRAI nicht wesentlich.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small restricted-stock grant to director; positive signal but economically immaterial.

The Form 4 shows a routine board equity grant—696 shares valued at roughly US$0.1 m—awarded to Director Christine Rose Detrick. Her total direct holdings rise to 6,139 shares, maintaining governance alignment without meaningful dilution. Because the grant value is de minimis relative to CRAI’s market cap and no cash purchase occurred, I view the filing as neutral for valuation or near-term stock performance, though it modestly reinforces insider confidence.

Deposito del Modulo 4 di CRA International (CRAI): La direttrice Christine Rose Detrick ha ricevuto 696 azioni ordinarie il 17 luglio 2025 al prezzo di $0, portando la sua partecipazione diretta a 6.139 azioni. Il premio consiste in azioni vincolate che maturano il 25% ogni anno a partire dal primo anniversario della concessione, favorendo un allineamento a lungo termine con gli azionisti. Non sono stati esercitati derivati né sono state vendute o trasferite azioni. L'incremento aumenta la quota della direttrice di circa il 13%, ma rappresenta meno dello 0,01% delle azioni in circolazione della società, quindi la diluizione e l'impatto sul mercato sono trascurabili. Sebbene l'accumulazione da parte degli insider sia un segnale positivo, il valore economico è modesto e non modifica sostanzialmente la struttura del capitale o la tesi d'investimento di CRAI.

Presentación del Formulario 4 de CRA International (CRAI): La directora Christine Rose Detrick recibió 696 acciones ordinarias el 17 de julio de 2025 a $0, aumentando su propiedad directa a 6,139 acciones. La concesión consiste en acciones restringidas que se liberan en un 25% anual a partir del primer aniversario de la concesión, fomentando una alineación a largo plazo con los accionistas. No se ejercieron derivados ni se vendieron o transfirieron acciones. Esta adición incrementa la participación de la directora en aproximadamente un 13%, pero representa menos del 0,01% de las acciones en circulación de la empresa, por lo que la dilución y el impacto en el mercado son insignificantes. Aunque la acumulación interna es un signo positivo, el valor económico es modesto y no altera materialmente la estructura de capital ni la tesis de inversión de CRAI.

CRA International (CRAI) Form 4 제출: 이사 Christine Rose Detrick는 2025년 7월 17일에 696주의 보통주를 $0에 받았으며, 직접 소유 주식 수는 6,139주로 증가했습니다. 이 수여는 제한 주식으로, 부여 1주년부터 매년 25%씩 베스팅되어 주주와의 장기적 일치를 촉진합니다. 파생상품 행사는 없었고 주식도 매도 또는 이전되지 않았습니다. 이번 추가로 이사의 지분은 약 13% 증가했지만, 회사 발행 주식의 0.01% 미만에 해당하여 희석 및 시장 영향은 미미합니다. 내부자 매입은 긍정적인 신호이나 경제적 가치는 크지 않으며 CRAI의 자본 구조나 투자 논리를 실질적으로 변경하지 않습니다.

Dépôt du formulaire 4 de CRA International (CRAI) : La directrice Christine Rose Detrick a reçu 696 actions ordinaires le 17 juillet 2025 à 0 $, portant sa participation directe à 6 139 actions. Cette attribution correspond à des actions restreintes qui se libèrent à hauteur de 25 % chaque année à partir du premier anniversaire de la concession, favorisant ainsi un alignement à long terme avec les actionnaires. Aucun dérivé n’a été exercé et aucune action n’a été vendue ou transférée. Cette augmentation accroît la participation de la directrice d’environ 13 %, mais représente bien moins de 0,01 % des actions en circulation de la société, de sorte que la dilution et l’impact sur le marché sont négligeables. Bien que l’accumulation par les initiés soit un signal positif, la valeur économique reste modeste et ne modifie pas substantiellement la structure du capital ni la thèse d’investissement de CRAI.

CRA International (CRAI) Form 4 Einreichung: Direktorin Christine Rose Detrick erhielt am 17. Juli 2025 696 Stammaktien zu $0, wodurch ihr Direktbesitz auf 6.139 Aktien anstieg. Die Zuteilung besteht aus beschränkten Aktien, die ab dem ersten Jahrestag der Gewährung jährlich zu 25 % freigegeben werden, um eine langfristige Ausrichtung mit den Aktionären zu fördern. Es wurden keine Derivate ausgeübt und keine Aktien verkauft oder übertragen. Die zusätzliche Beteiligung erhöht den Anteil der Direktorin um etwa 13 %, stellt jedoch weniger als 0,01 % der ausstehenden Aktien des Unternehmens dar, sodass Verwässerung und Markteinfluss vernachlässigbar sind. Obwohl die Insider-Akkumulation positiv zu bewerten ist, ist der wirtschaftliche Wert gering und ändert die Kapitalstruktur oder die Investmentthesis von CRAI nicht wesentlich.

0001219601false00012196012025-07-212025-07-210001219601exch:XNYS2025-07-212025-07-210001219601exch:XNYScck:SevenAnd38DebenturesDue2026Member2025-07-212025-07-210001219601exch:XNYScck:SevenAnd12DebenturesDue2096Member2025-07-212025-07-21

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________
 
FORM 8-K
____________
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): July 21, 2025
 
CROWN HOLDINGS, INC.
 (Exact name of Registrant as specified in its charter)
Pennsylvania 001-41550 75-3099507
(State or Other Jurisdiction of
Incorporation or Organization)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
 
14025 Riveredge Drive, Suite 300
Tampa, Florida 33637
(215) 698-5100
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices)
 
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12) 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company   
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    





 
Title of each classTrading SymbolsName of each exchange on which registered
Common Stock $5.00 Par ValueCCKNew York Stock Exchange
7 3/8% Debentures Due 2026CCK26New York Stock Exchange
7 1/2% Debentures Due 2096CCK96New York Stock Exchange





TABLE OF CONTENTS


Item 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS

SIGNATURE

INDEX TO EXHIBITS

EX-99 PRESS RELEASE

























2




Item 2.02. Results of Operations and Financial Condition
On July 21, 2025 Crown Holdings, Inc. issued a press release announcing its earnings for the second quarter ended June 30, 2025. A copy of the press release is attached hereto as Exhibit 99 and incorporated herein by reference.

The information in this Report shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liability of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(c) Exhibits.

The following is furnished as an exhibit to this report.
99     Press release, dated July 21, 2025, issued by Crown Holdings, Inc.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).





















3




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CROWN HOLDINGS, INC.
By:/s/ Christy L. Kalaus
Christy L. Kalaus
Vice President and Corporate Controller



Dated: July 21, 2025



















4


FAQ

What insider transaction did CRAI disclose on the 21-Jul-2025 Form 4?

Director Christine Rose Detrick was granted 696 restricted shares of CRAI common stock on 17 Jul 2025.

How many CRAI shares does Director Detrick now own?

Following the grant, she beneficially owns 6,139 shares directly.

At what price were the new CRAI shares acquired?

The shares were issued at $0 under a restricted stock award—no cash outlay was required.

What is the vesting schedule for the 696 restricted shares?

They vest in four equal annual installments beginning one year after the 17 Jul 2025 grant date.

Does the filing include any derivative securities or sales?

No. Only non-derivative stock was reported and no shares were sold or disposed.
Crown Holdings

NYSE:CCK

CCK Rankings

CCK Latest News

CCK Latest SEC Filings

CCK Stock Data

12.48B
115.26M
0.91%
102.67%
5.21%
Packaging & Containers
Metal Cans
Link
United States
TAMPA